# Kadish C/Hyams II Esthesioneuroblastoma With Atypical Immunophenotype Mimicking NK/T-Cell Lymphoma: Endoscope-Assisted Transcranial Resection and Adjuvant Intensity-Modulated Radiotherapy

**Authors:** Cristina Vanessa Cuevas Calla, Antonio de Jesús González Luna, Nancy Cristina Vela Moya, Marco Antonio Castellanos López, Guadalupe Conejo Flores, Valeria Abril Marcos Rosas

PMC · DOI: 10.7759/cureus.95351 · Cureus · 2025-10-24

## TL;DR

A rare case of esthesioneuroblastoma with an unusual appearance was successfully treated using a specialized surgical and radiation approach.

## Contribution

Demonstrates a successful surgical and adjuvant treatment strategy for a rare tumor with an atypical immunophenotype.

## Key findings

- The tumor was initially misdiagnosed as NK/T-cell lymphoma but was confirmed as esthesioneuroblastoma using targeted immunohistochemistry.
- Endoscope-assisted transcranial resection achieved gross total tumor removal with multilayer reconstruction.
- Adjuvant intensity-modulated radiotherapy was safely delivered without complications, and the patient remains stable.

## Abstract

We present a case of an esthesioneuroblastoma (ENB; olfactory neuroblastoma) with an atypical immunophenotype managed by a combined transcranial, endoscope-assisted resection, illustrating diagnostic challenges and surgical decision-making when the anterior skull base and orbit are involved. A 66-year-old woman had recurrent left epistaxis, progressive unilateral nasal obstruction, periorbital pain radiating to the auricle, and ipsilateral visual decline. Examination showed swelling and tenderness over the left nasal region with no lymphadenopathy. Computed tomography (CT) and magnetic resonance imaging (MRI) demonstrated a left sinonasal mass extending to the medial orbit, with erosion of the lamina papyracea and cribriform plate, abutment of the anterior skull base, and molding of the medial rectus without definite intraconal invasion. The initial biopsy suggested natural killer/T-cell (NK/T-cell) lymphoma. Targeted immunohistochemistry (IHC) showed CD56 positivity with a sustentacular S100 pattern, a Ki-67 index of 30%-40%, and negativity for CD3, CD20, granzyme B, T-cell intracellular antigen-1 (TIA-1), chromogranin, and synaptophysin, confirming Kadish C/Hyams II ENB. A bifrontal, endoscope-assisted craniectomy achieved gross total resection and multilayer reconstruction (onlay dural collagen matrix; titanium mesh and polymethylmethacrylate (PMMA) for the anterior skull base; titanium mesh for the orbital roof). Postoperative CT showed no gross residual mass, decompression of the medial rectus, and minimal expected pneumocephalus. Adjuvant intensity-modulated radiotherapy (IMRT) to the surgical bed/anterior skull base was delivered (60 Gy in 30 fractions); elective neck irradiation was individualized. The patient remains stable under multidisciplinary surveillance. Key lessons include broadening the IHC panel to avoid misclassification as NK/T-cell lymphoma when classic neuroendocrine markers are negative, considering a transcranial, endoscope-assisted approach to obtain margins and a stable reconstruction when the anterior skull base/orbit are involved, and obtaining early postoperative imaging as a baseline for surveillance.

## Linked entities

- **Proteins:** NCAM1 (neural cell adhesion molecule 1), S100A1 (S100 calcium binding protein A1), cd.3 (Cd.3 conserved hypothetical protein), MS4A1 (membrane spanning 4-domains A1)
- **Diseases:** esthesioneuroblastoma (MONDO:0016029), NK/T-cell lymphoma (MONDO:0019472)

## Full-text entities

- **Genes:** KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, TIA1 (TIA1 cytotoxic granule associated RNA binding protein) [NCBI Gene 7072] {aka ALS26, TIA-1, WDM}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}
- **Diseases:** NK/T-Cell Lymphoma (MESH:D016399), pneumocephalus (MESH:D011007), NK/T-cell lymphoma (MESH:D000077428), nasal obstruction (MESH:D015508), pain (MESH:D010146), epistaxis (MESH:D004844), ENB (MESH:D018304), tenderness (MESH:D063806), swelling (MESH:D004487), Hyams II (MESH:C537730), C (OMIM:211750), lymphadenopathy (MESH:D008206), visual decline (MESH:D014786)
- **Chemicals:** titanium (MESH:D014025), PMMA (MESH:D019904)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12641343/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12641343/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12641343/full.md

---
Source: https://tomesphere.com/paper/PMC12641343